Fargesone B

Fargesone B
Product Name Fargesone B
CAS No.: 116424-70-5
Catalog No.: CFN96260
Molecular Formula: C21H24O6
Molecular Weight: 372.4 g/mol
Purity: >=98%
Type of Compound: Lignans
Physical Desc.: Oil
Targets: Calcium Channel | cAMP
Source: The flowers of Magnolia fargesii
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
Fargesone B inhibits the vascular smooth muscle contraction by suppressing the voltage- and receptor-activated calcium influxes in a nonselective manner.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • National Academy Science Letters2023, s40009.
  • Molecular & Cellular Toxicology2017, 13(3):271-278
  • BioResources J.2020, 15(3).
  • J Med Food.2016, 19(12):1155-1165
  • Sci Rep.2023, 13(1):14594.
  • Molecules.2023, 28(16):6025.
  • BMC Pharmacol Toxicol.2018, 19(1):5
  • J Microbiol Biotechnol.2020, 30(2):178-186.
  • Viruses.2024, 16(7):1128.
  • Anat Rec (Hoboken).2021, 304(2):323-332.
  • 2-Epi-3a-epiburchellin

    Catalog No: CFN96707
    CAS No: 57457-99-5
    Price: Inquiry(manager@chemfaces.com)
    Isofutoquinol A

    Catalog No: CFN91836
    CAS No: 62499-70-1
    Price: $388/5mg
    Hancinone C

    Catalog No: CFN97876
    CAS No: 111843-10-8
    Price: Inquiry(manager@chemfaces.com)
    Wallichinine

    Catalog No: CFN96307
    CAS No: 125292-97-9
    Price: Inquiry(manager@chemfaces.com)
    Futoquinol

    Catalog No: CFN96249
    CAS No: 28178-92-9
    Price: $388/5mg
    Isodihydrofutoquinol B

    Catalog No: CFN96400
    CAS No: 62499-71-2
    Price: Inquiry(manager@chemfaces.com)
    Isodihydrofutoquinol A

    Catalog No: CFN96401
    CAS No: 62560-95-6
    Price: Inquiry(manager@chemfaces.com)
    Fargesone A

    Catalog No: CFN96245
    CAS No: 116424-69-2
    Price: Inquiry(manager@chemfaces.com)
    Fargesone B

    Catalog No: CFN96260
    CAS No: 116424-70-5
    Price: Inquiry(manager@chemfaces.com)
    1,6-Dihydro-4,7'-epoxy-1-methoxy-3',4'-methylenedioxy-6-oxo-3,8'-lignan

    Catalog No: CFN96289
    CAS No: 67920-48-3
    Price: Inquiry(manager@chemfaces.com)
    Asia Pacif. J. Pharmacol.,1990,v.5:213-8.
    Vasorelaxation of Rat Aorta by Fargesone B Isolated from the Flower buds of Magnolia Fargesii[Reference: WebLink]
    The effect of Fargesone B, isolated from Magnolia fargesii, on the contraction of rat aorta was studied.
    METHODS AND RESULTS:
    Fargesone B suppressed the contraction of aortic rings caused by cumulative concentrations of calcium (0.03-3 mM) in high potassium (60 mM) medium, with an IC50 of 12 .mu.g ml-1. It also relaxed the norepinephrine (NE, 3 .mu.M)-induced contraction, and its pretreatment inhibited both the phasic and tonic contractions elicited by NE, with an IC50 of about 100 and 30 .mu.g ml-1, respectively. This inhibition was also observed in the absence of calcium in the medium. It did not inhibit caffeine-induced phasic contraction. In quin-2-loaded cultured vascular smooth muscle cells, Fargesone B suppressed the rise of intracellular calcium caused by NE but not that by caffeine. 45Ca++ uptake by NE was also concentration-dependently inhibited by Fargesone B. Fargesone B did not change the levels of PGI2, cGMP or cAMP of rat aorta.
    CONCLUSIONS:
    It is concluded that Fargesone B inhibits the vascular smooth muscle contraction by suppressing the voltage- and receptor-activated calcium influxes in a nonselective
    Kakkalide

    Catalog No: CFN95052
    CAS No: 58274-56-9
    Price: $260/10mg
    Astin A

    Catalog No: CFN95187
    CAS No: 151201-75-1
    Price: $318/10mg
    Arisantetralone B

    Catalog No: CFN95211
    CAS No: 1161947-96-1
    Price: $413/5mg
    Cuscutamine

    Catalog No: CFN95323
    CAS No: 122170-93-8
    Price: $318/5mg
    Norwogonin-8-O-glucuronide

    Catalog No: CFN95423
    CAS No: 118525-47-6
    Price: $368/5mg
    11beta,13-Dihydrolactucin

    Catalog No: CFN95433
    CAS No: 83117-63-9
    Price: $318/10mg
    Ganoderenic acid K

    Catalog No: CFN95469
    CAS No: 942950-94-9
    Price: $318/10mg
    Maingayone

    Catalog No: CFN95479
    CAS No: 271585-66-1
    Price: $318/10mg
    Ganoderenic acid G

    Catalog No: CFN95517
    CAS No: 120481-73-4
    Price: $318/5mg
    Tembetarine

    Catalog No: CFN95542
    CAS No: 18446-73-6
    Price: $318/5mg